Free Trial

biote Q1 2023 Earnings Report

biote logo
$6.50 +0.15 (+2.36%)
(As of 12:51 PM ET)

biote EPS Results

Actual EPS
$0.94
Consensus EPS
$0.09
Beat/Miss
Beat by +$0.85
One Year Ago EPS
N/A

biote Revenue Results

Actual Revenue
$44.84 million
Expected Revenue
$43.38 million
Beat/Miss
Beat by +$1.46 million
YoY Revenue Growth
N/A

biote Announcement Details

Quarter
Q1 2023
Time
N/A
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

>> Register for the Workshop Now

biote Earnings Headlines

Craig-Hallum bullish on Biote, initiates with a Buy
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.
Biote Reports Third Quarter 2024 Financial Results
See More biote Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like biote? Sign up for Earnings360's daily newsletter to receive timely earnings updates on biote and other key companies, straight to your email.

About biote

biote (NASDAQ:BTMD) operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

View biote Profile

More Earnings Resources from MarketBeat

Upcoming Earnings